These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23252785)

  • 1. Letter: diagnostic accuracy of M30 levels for identifying patients with non-alcoholic steatohepatitis--authors' reply.
    Shen J; Wong VW
    Aliment Pharmacol Ther; 2013 Jan; 37(2):283-4. PubMed ID: 23252785
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: diagnostic accuracy of M30 levels for identifying patients with non-alcoholic steatohepatitis.
    Yilmaz Y
    Aliment Pharmacol Ther; 2013 Jan; 37(2):283. PubMed ID: 23252784
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary: assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers--authors' reply.
    Shen J; Wong VW
    Aliment Pharmacol Ther; 2013 Jan; 37(2):276. PubMed ID: 23252777
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.
    Miller MH; Dillon JF
    Aliment Pharmacol Ther; 2013 Jan; 37(2):275. PubMed ID: 23252776
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.
    Shen J; Chan HL; Wong GL; Chan AW; Choi PC; Chan HY; Chim AM; Yeung DK; Yu J; Chu WC; Wong VW
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1057-66. PubMed ID: 23066946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cytokeratin-18 fragment level: a noninvasive biomarker for not only nonalcoholic steatohepatitis, but also alcoholic steatohepatitis.
    Li X; Zhang Y; Wu K; Fan D
    Hepatology; 2010 May; 51(5):1865-6. PubMed ID: 20041411
    [No Abstract]   [Full Text] [Related]  

  • 7. Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease.
    Mueller S; Nahon P; Rausch V; Peccerella T; Silva I; Yagmur E; Straub BK; Lackner C; Seitz HK; Rufat P; Sutton A; Bantel H; Longerich T
    Hepatology; 2017 Jul; 66(1):96-107. PubMed ID: 28170108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease.
    Ergelen R; Akyuz U; Aydin Y; Eren F; Yilmaz Y
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):667-71. PubMed ID: 25923941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of serum M30 and M65 in chronic hepatitis B patients with non-alcoholic fatty liver disease.
    Liang J; Han T; Gao YT; Jing L; Ma Z
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4123-9. PubMed ID: 26592838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina.
    Valva P; Rios D; Casciato P; Gadano A; Galdame O; Mullen E; Bertot G; de Matteo E; Preciado MV
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):637-644. PubMed ID: 29384795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An apoptosis biomarker for prediction of nonalcoholic steatohepatitis.
    Bantel H; Bahr MJ; Schulze-Osthoff K
    Hepatology; 2009 Sep; 50(3):991. PubMed ID: 19593820
    [No Abstract]   [Full Text] [Related]  

  • 12. Caspase-cleaved keratin 18 as a biomarker for non-alcoholic steatohepatitis (NASH) - the need for correct terminology.
    Linder S
    J Hepatol; 2011 Dec; 55(6):1467. PubMed ID: 21763667
    [No Abstract]   [Full Text] [Related]  

  • 13. High Circulating Caspase-Cleaved Keratin 18 Fragments (M30) Indicate Short-Term Mortality in Critically Ill Patients.
    Koch A; Yagmur E; Linka J; Schumacher F; Bruensing J; Buendgens L; Herbers U; Koek GH; Weiskirchen R; Trautwein C; Tacke F
    Dis Markers; 2018; 2018():8583121. PubMed ID: 30069276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children.
    Feldstein AE; Alkhouri N; De Vito R; Alisi A; Lopez R; Nobili V
    Am J Gastroenterol; 2013 Sep; 108(9):1526-31. PubMed ID: 23752877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of M30, an apoptotic serum marker, in liver diseases.
    Altinbaş A; Çoban Ş; Başar Ö; Yüksel O
    Turk J Med Sci; 2015; 45(1):6-10. PubMed ID: 25790523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratin-18 as a marker of steatohepatitis.
    Gonzalez-Quintela A; Lojo S; Otero E; Perez LF
    Hepatology; 2007 Feb; 45(2):545. PubMed ID: 17256723
    [No Abstract]   [Full Text] [Related]  

  • 17. Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis?
    Hashimoto E; Farrell GC
    J Gastroenterol Hepatol; 2009 Apr; 24(4):501-3. PubMed ID: 19368628
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Wierzbicka A; Socha P; Pronicki M; Skiba E; Werpachowska I; Kaczmarski M
    Acta Biochim Pol; 2011; 58(4):563-6. PubMed ID: 22140659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Cleaved) CK18 serum and tissue expression levels differentiate acute HCV reinfection from acute rejection in liver allografts.
    Reis H; Wohlschläger J; Hagemann S; Wenzel P; Bechmann LP; Suttorp AC; Schlattjan MJ; Herzer K; Canbay A; Baba HA
    Liver Int; 2015 Mar; 35(3):905-13. PubMed ID: 24750688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is M65 really better than M30 as a biomarker of hepatic fibrosis?
    Yilmaz Y; Kurt R
    Hepatology; 2012 Feb; 55(2):654; author reply 654-5. PubMed ID: 22161311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.